Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk

Early percutaneous coronary intervention (PCI) and long-term aggressive antithrombotic treatment based on dual antiplatelet therapy (DAPT) are the most important elements in the treatment of patients with acute coronary syndrome (ACS). The most studied and recommended for ACS is the 12-month DAPT (c...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteur:	O. V. Averkov
Formaat:	Artigo
Taal:	Russo
Gepubliceerd in:	«FIRMA «SILICEA» LLC 2021-02-01
Reeks:	Российский кардиологический журнал
Onderwerpen:	acute coronary syndrome percutaneous coronary intervention dual antiplatelet therapy bleeding risk acetylsalicylic acid discontinuation clopidogrel ticagrelor prasugrel
Online toegang:	https://russjcardiol.elpub.ru/jour/article/view/4305
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!